Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study
Construction and Preliminary Verification of interventionImpact of an IMB Theory-based Health Education Intervention on Hypoglycemic Coping in Patients With Type 2 Diabetes: a Pilot Study
1 other identifier
interventional
100
1 country
1
Brief Summary
From August 2023 to January 2024, 100 patients with type 2 diabetes who met the inclusion and exclusion criteria were selected from the endocrinology department of The purpose of this study was to construct a hypoglycemia coping intervention program for type 2 diabetic patients based on the IMB theory and to investigate the feasibility, acceptability, and initial effects of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Aug 2023
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedApril 25, 2024
April 1, 2024
6 months
January 17, 2024
April 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The hypoglycemic coping style
The scale consists of 16 entries in 3 dimensions, which in this study are confrontation (entries 1, 6, 8, 11, 12, 15), avoidance (entries 2, 5, 7, 10, 13, 16), and submission (entries 3, 4, 9, 14), and each of the entries is rated on a Likert's 5 scale ranging from 0-4, with higher scores on the dimensions indicating a greater tendency toward this type of coping, and the scale's total Cronbach's alpha coefficient was 0.821.
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Secondary Outcomes (5)
hypoglycemic fear behavioral
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Hypoglycemia fear worry
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Level of health information access behavior
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Level of health beliefs
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Level of diabetes knowledge
Baseline, 4 weeks, 8 weeks and 12 weeks post-intervention
Study Arms (2)
intervention group
EXPERIMENTALBased on IMB Theory of Health Education A hypoglycemia coping intervention program based on IMB theory was implemented on top of the control group.
the control group
NO INTERVENTIONGeneral diabetes health education Patients were provided with regular medication guidance, dietary guidance, exercise guidance and popularization of related diabetes knowledge; regular daily blood glucose testing and recording; and timely answers to patients' clinical problems and psychological support.
Interventions
Based on IMB health education theory Questionnaire collection, face-to-face interview, and manual interpretation on the first day of admission; questionnaire collection, face-to-face interview, and manual interpretation on the first day of admission; hypoglycemia knowledge promotion on the second day; Peer experience sharing on the third day; access to WeChat group and knowledge pushing on the fourth day; hypoglycemia-related lectures and practical teaching on the fifth day, face-to-face teaching and development of blood glucose management plan. Hypoglycemia knowledge contest on the day before discharge; One week, two weeks and three weeks after discharge for WeChat push or phone call; WeChat push, phone call and questionnaire.
Eligibility Criteria
You may qualify if:
- Patients who meet the 2018 ADA medical standards for Diabetes diagnosis and treatment, are diagnosed with T2DM and use insulin or sulfonylurea drugs;
- Duration of diabetes mellitus ≥1 year
- Age ≥18 years old;
- A history of hypoglycemia in the past 6 months;
- Type 2 diabetes patients with hypoglycemia coping style questionnaire inclination, avoidance, compromise;
- Good communication and language skills;
- Have a smartphone and can use it;
- Voluntary participation in this study.
You may not qualify if:
- Patients with type 1 diabetes;
- Patients with type 2 diabetes combined with serious complications;
- Patients who have recently or are participating in other similar studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yating Liulead
Study Sites (1)
Ya ting Liu
Yangzhou, 未选择, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ya T Liu, Bachelor
Yangzhou University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- supervisor nurse
Study Record Dates
First Submitted
January 17, 2024
First Posted
April 25, 2024
Study Start
August 1, 2023
Primary Completion
January 17, 2024
Study Completion
January 17, 2024
Last Updated
April 25, 2024
Record last verified: 2024-04